Skin Changes in Iatrogenic Cushing’s Syndrome: A Detailed Case Analysis

Authors

  • Nanda Earlia Department of Dermatology and Venereology, Faculty of Medicine Universitas Syiah Kuala, Banda Aceh 23111, Indonesia; Department of Dermatology and Venereology, Dr. Zainoel Abidin Hospital, Banda Aceh 23111, Indonesia
  • Mimi Maulida Department of Dermatology and Venereology, Faculty of Medicine Universitas Syiah Kuala, Banda Aceh 23111, Indonesia; Department of Dermatology and Venereology, Dr. Zainoel Abidin Hospital, Banda Aceh 23111, Indonesia
  • Vella Vella Department of Dermatology and Venereology, Faculty of Medicine Universitas Syiah Kuala, Banda Aceh 23111, Indonesia; Department of Dermatology and Venereology, Dr. Zainoel Abidin Hospital, Banda Aceh 23111, Indonesia
  • Aldilla Pradistha Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia
  • Wizurai Wisesa Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia
  • Abdur Razaq Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia
  • Tubagus Pasca Faiz Ikram Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia
  • Muhammad Zahrul Rahmatillah Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia
  • Bianda Sabrina Farsa Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia
  • Fajri Alghani Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia

DOI:

https://doi.org/10.60084/ijcr.v2i2.243

Keywords:

Iatrogenic Cushing's syndrome, Corticosteroid, Erythematous purulent lesions, Atrophic striae

Abstract

Cushing's syndrome can lead to various skin complications. Iatrogenic Cushing's syndrome is a condition caused by excessive exogenous glucocorticoid exposure. This case report presents a patient with a history of Cushing's syndrome and long-term corticosteroid use who developed multiple skin manifestations. A 20-year-old male presented with erythematous purulent lesions on the face, neck, chest, and back. Concurrently, the patient developed purplish-red striae on the chest, abdomen, arms, and legs. Physical examination revealed erythematous nodules and pustules, along with atrophic striae. Laboratory tests showed leukocytosis with a left shift and hypokalemia. Radiological investigations revealed lumbar spondylosis and cardiomegaly. The patient was treated with a combination therapy, including topical and systemic medications, and showed significant improvement in skin lesions. This case highlights the importance of a comprehensive evaluation for patients presenting with unusual skin lesions. A thorough history, physical examination, and laboratory investigations are crucial to identify underlying conditions and initiate appropriate treatment.

Downloads

Download data is not yet available.

References

  1. Kumar, S., Kumar, S., Khanduri, S., Jethani, V., Kumar, M., and Khanduri, R. S. (2021). Prevalence of Clinical Iatrogenic Cushing’s Syndrome and its Contributing Factors in Patients with Chronic Obstructive Airway Disease, Journal of Cardio-Thoracic Medicine, Vol. 9, No. 4, 884–890.
  2. Neupane, S. kiran, Jaishi, P. P., Koirala, D., and Neupane, P. K. (2022). Steroid as Double Edged Sword; a Catastrophic Event in the Rural Part of Nepal, Annals of Medicine & Surgery, Vol. 82. doi:10.1016/j.amsu.2022.104697.
  3. Lause, M., Kamboj, A., and Fernandez Faith, E. (2017). Dermatologic Manifestations of Endocrine Disorders, Translational Pediatrics, Vol. 6, No. 4, 300–312. doi:10.21037/tp.2017.09.08.
  4. Stanley, T., and Misra, M. (2021). Endocrine Conditions in Pediatrics, Springer International Publishing, Cham. doi:10.1007/978-3-030-52215-5.
  5. Sharma, S. T., and Nieman, L. K. (2011). Cushing’s Syndrome: All Variants, Detection, and Treatment, Endocrinology and Metabolism Clinics of North America, Vol. 40, No. 2, 379–391. doi:10.1016/j.ecl.2011.01.006.
  6. Feelders, R., Sharma, S., and Nieman, L. (2015). Cushing’s Syndrome: Epidemiology and Developments in Disease Management, Clinical Epidemiology, 281. doi:10.2147/CLEP.S44336.
  7. Simacek, K. (2018). A Theory of Misdiagnosis: A Qualitative Analysis of the Diagnosis Journey for an Ambiguous, Visible Disease With Stigmatizing Symptoms, [Bloomington, Ind.]: Indiana University.
  8. Winter, W., Sokoll, L. J., Holmquist, B., and Bertholf, R. L. (2020). Handbook of Diagnostic Endocrinology, Academic Press.
  9. Alkhuder, L., and Mawlawi, H. (2019). Infantile Iatrogenic Cushing Syndrome due to Topical Steroids, Case Reports in Pediatrics, Vol. 2019, 1–4. doi:10.1155/2019/2652961.
  10. Baker, E. (2021). Is There a Safe and Effective Way to Wean Patients off Long-Term Glucocorticoids?, British Journal of Clinical Pharmacology, Vol. 87, No. 1, 12–22. doi:10.1111/bcp.14679.
  11. Farzanfar, D., Dowlati, Y., French, L. E., Lowes, M. A., and Alavi, A. (2018). Inflammation: A Contributor to Depressive Comorbidity in Inflammatory Skin Disease, Skin Pharmacology and Physiology, Vol. 31, No. 5, 246–251. doi:10.1159/000490002.
  12. Lee, D. K., and Lipner, S. R. (2022). Optimal Diagnosis and Management of Common Nail Disorders, Annals of Medicine, Vol. 54, No. 1, 694–712. doi:10.1080/07853890.2022.2044511.
  13. Kang, S., Amagai, M., Bruckner, A. L., Enk, A. H., Margolis, D. J., McMichael, A. J., and Orringer, J. S. (2019). Fitzpatrick’s Dermatology 9th Edition, McGraw-Hill Education.
  14. Picard, D., Sellier, S., Houivet, E., Marpeau, L., Fournet, P., Thobois, B., Bénichou, J., and Joly, P. (2015). Incidence and Risk Factors for Striae Gravidarum, Journal of the American Academy of Dermatology, Vol. 73, No. 4, 699–700. doi:10.1016/j.jaad.2015.06.037.
  15. Özgüç Çömlek, F., Örüm, S., Aydın, S., and Tütüncüler, F. (2018). Exogenous Cushing Syndrome Due to Misuse of Potent Topical Steroid, Pediatric Dermatology, Vol. 35, No. 2. doi:10.1111/pde.13409.
  16. Güven, A. (2020). Different Potent Glucocorticoids, Different Routes of Exposure but the Same Result: Iatrogenic Cushing’s Syndrome and Adrenal Insufficiency, Journal of Clinical Research in Pediatric Endocrinology, Vol. 12, No. 4, 383–392. doi:10.4274/jcrpe.galenos.2020.2019.0220.
  17. Colao, A., Boscaro, M., Ferone, D., and Casanueva, F. F. (2014). Managing Cushing’s Disease: The State of the Art, Endocrine, Vol. 47, No. 1, 9–20. doi:10.1007/s12020-013-0129-2.
  18. Kreitschmann-Andermahr, I., Psaras, T., Tsiogka, M., Starz, D., Kleist, B., Siegel, S., Milian, M., Kohlmann, J., Menzel, C., Führer-Sakel, D., Honegger, J., Sure, U., Müller, O., and Buchfelder, M. (2015). From First Symptoms to Final Diagnosis of Cushing’s Disease: Experiences of 176 Patients, European Journal of Endocrinology, Vol. 172, No. 3, 285–289. doi:10.1530/EJE-14-0766.
  19. Reincke, M., and Fleseriu, M. (2023). Cushing Syndrome, JAMA, Vol. 330, No. 2, 170. doi:10.1001/jama.2023.11305.
  20. Karaca, Z., Taheri, S., Firat, S. T., Borlu, M., Zararsiz, G., Mehmetbeyoglu, E., Caglar, A. S., Hacioglu, A., Tanriverdi, F., Unluhizarci, K., and Kelestimur, F. (2021). Molecular Skin Changes in Cushing Syndrome and the Effects of Treatment, Journal of Endocrinological Investigation, Vol. 44, No. 1, 153–163. doi:10.1007/s40618-020-01285-7.
  21. Gupta, M., Aggarwal, M., and Bhari, N. (2018). Acneiform Eruptions: An Unusual Dermatological Side Effect of Ribavirin, Dermatologic Therapy, Vol. 31, No. 5, e12679. doi:10.1111/dth.12679.
  22. Igaz, P., Rácz, K., Tóth, M., Gláz, E., and Tulassay, Z. (2007). Treatment of Iatrogenic Cushing’s Syndrome: Questions of Glucocorticoid Withdrawal, Hungarian Medical Journal, Vol. 1, No. 1, 63–72. doi:10.1556/OH-HMJ.2007.27964.
  23. Rangel Bonamigo, R. (Ed.). (2023). Dermatology in Public Health Environments, Springer International Publishing, Cham. doi:10.1007/978-3-031-13505-7.
  24. Beshay, A., Petersen, M., and Rhoads, J. L. W. (2021). Severe EGFR Inhibitor-Induced Acneiform Eruption Responding to Dapsone, Dermatology Online Journal, Vol. 27, No. 7. doi:10.5070/D327754366.
  25. Truitt, J. M., Reichenberg, J. S., Sharghi, K. G., Sampson, S. M., Roenigk, R. K., and Magid, M. (2018). Isotretinoin: The Ups Are Just As Troubling As the Downs, Italian Journal of Dermatology and Venereology, Vol. 153, No. 4. doi:10.23736/S0392-0488.18.05979-5.
  26. Ud‐Din, S., McGeorge, D., and Bayat, A. (2016). Topical Management of Striae Distensae (Stretch Marks): Prevention and Therapy of Striae Rubrae and Albae, Journal of the European Academy of Dermatology and Venereology, Vol. 30, No. 2, 211–222. doi:10.1111/jdv.13223.
  27. Ambar Aliwardani, Putti Fatiharani Dewi, Fiska Rosita, and Indah Julianto. (2023). Modalitas Terapi Striae, MEDICINUS, Vol. 36, No. 2, 42–50. doi:10.56951/medicinus.v36i2.124.
  28. Navarro-Triviño, F. J., Arias-Santiago, S., and Gilaberte-Calzada, Y. (2019). Vitamin D and the Skin: A Review for Dermatologists, Actas Dermo-Sifiliográficas (English Edition), Vol. 110, No. 4, 262–272. doi:10.1016/j.adengl.2019.04.001.

Downloads

Published

2024-12-22

How to Cite

Earlia, N., Maulida, M., Vella, V., Pradistha, A. ., Wisesa, W., Razaq, A., Ikram, T. P. F., Rahmatillah, M. Z., Farsa, B. S., & Alghani, F. (2024). Skin Changes in Iatrogenic Cushing’s Syndrome: A Detailed Case Analysis. Indonesian Journal of Case Reports, 2(2), 52–57. https://doi.org/10.60084/ijcr.v2i2.243